XprESS Eustachian Tube Dilation Study
Sponsor: Entellus Medical, Inc.
Listed as NCT02391584, this NA trial focuses on Eustachian Tube Dysfunction and remains completed. Sponsored by Entellus Medical, Inc., it has been updated 10 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Feb 2020 — Jan 2021 [monthly]
Completed NA
-
Dec 2018 — Feb 2020 [monthly]
Completed NA
▶ Show 5 earlier versions
-
Jun 2018 — Dec 2018 [monthly]
Completed NA
-
Mar 2018 — Jun 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Aug 2017 — Mar 2018 [monthly]
Active Not Recruiting NA
-
Feb 2017 — Aug 2017 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting NA
First recorded
Feb 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Entellus Medical, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .